SE309779B - - Google Patents

Info

Publication number
SE309779B
SE309779B SE2730/64A SE273064A SE309779B SE 309779 B SE309779 B SE 309779B SE 2730/64 A SE2730/64 A SE 2730/64A SE 273064 A SE273064 A SE 273064A SE 309779 B SE309779 B SE 309779B
Authority
SE
Sweden
Application number
SE2730/64A
Inventor
H Wuest
Original Assignee
Warner Lambert Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262846A external-priority patent/US3192200A/en
Application filed by Warner Lambert Pharmaceutical filed Critical Warner Lambert Pharmaceutical
Publication of SE309779B publication Critical patent/SE309779B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24—Oxygen atoms
    • C07D243/26—Preparation from compounds already containing the benzodiazepine skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE2730/64A 1963-03-05 1964-03-05 SE309779B (th)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US262846A US3192200A (en) 1963-03-05 1963-03-05 1-cycloalkyl methyl derivatives of 1, 4-benzodiazepine
US410790A US3326757A (en) 1963-03-05 1964-11-12 Compositions and method for producing skeletal muscle relaxation

Publications (1)

Publication Number Publication Date
SE309779B true SE309779B (th) 1969-04-08

Family

ID=26949494

Family Applications (1)

Application Number Title Priority Date Filing Date
SE2730/64A SE309779B (th) 1963-03-05 1964-03-05

Country Status (8)

Country Link
US (1) US3326757A (th)
BE (1) BE644705A (th)
BR (1) BR6457243D0 (th)
CH (1) CH427830A (th)
DE (1) DE1470422A1 (th)
FR (1) FR3452M (th)
GB (1) GB1029741A (th)
SE (1) SE309779B (th)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8778264B2 (en) 2010-10-28 2014-07-15 Guy L. McClung, III Fluid treatment systems
US8911676B2 (en) 2010-10-21 2014-12-16 Guy L. McClung, III Treatment systems for fluids

Also Published As

Publication number Publication date
BR6457243D0 (pt) 1973-07-17
US3326757A (en) 1967-06-20
FR3452M (fr) 1965-07-26
BE644705A (th) 1964-09-04
DE1470422A1 (de) 1969-11-13
CH427830A (de) 1967-01-15
GB1029741A (en) 1966-05-18

Similar Documents

Publication Publication Date Title
AR142945A1 (th)
BE627012A (th)
BE627151A (th)
BE507458A (th)
BE627023A (th)
BE626915A (th)
BE465565A (th)
BE644587A (th)
BE626358A (th)
BE625880A (th)
BE626826A (th)
BE624811A (th)
BE640480A (th)
BE462764A (th)
BE31062A (th)
BE603935A (th)
BE625136A (th)
BE644384A (th)
BE621232A (th)
BE533484A (th)
BE627145A (th)
BE643163A (th)
BE627172A (th)
BE620325A (th)
BE644936A (th)